OSP News

Blue Cross Complete Release Proton Pump Inhibitors De-prescribing Guidelines Outlined by the American Gastroenterological Association

Posted: 09/05/2024

Please be advised that some providers will soon receive a letter from Blue Cross Complete regarding an important update on the management of patients currently prescribed proton pump inhibitors. 

This letter will outline recommendations by the American Gastroenterological Association, indicating that all patients without a definitive indication for chronic PPI use be considered for a trial of de-prescribing. 

Providers should review the forthcoming communication carefully and prepare to assess their patients for potential changes in their PPI therapy. 

If you have any questions, contact your Blue Cross Complete provider account executive or the Blue Cross Complete Provider Inquiry at 1-888-312-5713.

We value your privacy. We use cookies and other technologies to keep the web site reliable and secure, tailor your experience, and measure web site performance, as described in our Privacy Policy.

x

OSP Technical Support